• Why this health tech group picked Nashville – not Silicon Valley — to help unlock the future of health care
    anemptytextlline
  • Distress Index: The third quarter 2014 results for the FBT/TrBK Distress Indices have just been released.
    anemptytextlline
  • Distress to Success: A Survival Handbook For Struggling Businesses and Buyers of distressed Opportunities
    anemptytextlline
  • Give your business the mirror test - is your company really breathing?
    anemptytextlline
  • Attacks Continue on Lenders’ Right to Credit Bid in 363 sales
    anemptytextlline
  • Antitrust Concerns May Block Section 363 Sales
    anemptytextlline
  • THE GREATEST THREAT TO R&D COMPANIES : A LOSS IN THE LAB
    anemptytextlline
  • INSURANCE & RISK MANAGEMENT: For Global Human Clinical Trials
    anemptytextlline
  • Three Bets At The Table: The Major Distressed Investing Strategies For Hedge Funds and Private Equity
    anemptytextlline
  • HOW PRO’S PLAY LOAN-TO-OWN GAME
    anemptytextlline
  • Hot Opportunities in a Cooling Economy: Buying Struggling Facilities at Distress Sales
    anemptytextlline
  • Why Up-Market, Down-Market Acquisitions are different
    anemptytextlline

THE GREATEST THREAT TO R&D COMPANIES : A LOSS IN THE LAB

lostinthelab

The Greatest Threat to R&D Companies: A Loss in the Lab

By Daniel Brettler,  Senior Vice President, Life Science & Technology Practice Leader, Conner Strong

Our country is facing one of the worst financial crises in more than a generation. Life science and technology companies face many of the same struggles seen throughout the country. Inability to raise capital, increased operating costs, increased global competition and increased governmental and industry regulations are just a few.

But, the greatest physical threat to life science and tech companies? A loss in the lab. It’s there that some of the most rewarding, and yet riskiest, work is performed in this country. Research and development projects consume vast resources—human and capital— and bumps in the road can greatly impact revenue, operating expenses, results, liability and property. Whether your business is creating a medical device or discovering a new vaccine, it’s your research lab that offers the greatest potential and greatest threat.  Read more